Contributing Authors | p. xiii |
Foreword | p. xxiii |
Preface | p. xxv |
Basic Mechanisms of Epileptogenesis | |
Cellular Aspects of Epileptogenesis | |
Basic Cellular Neurophysiology | p. 3 |
Neurotransmitters and Receptors | p. 25 |
Mechanisms of Epileptogenesis and Experimental Models of Seizures | p. 33 |
Neuronal Migration Disorders: Developmental and Neuroanatomic Aspects | |
Brain Developmental Milestones and Pathologic Correlation | p. 45 |
Cerebral Dysgenesis and Epilepsy | p. 65 |
Cortical Anatomy: Normal and Abnormal Sulcal and Gyral Patterns | p. 79 |
Hippocampal Sclerosis: Neuroanatomic and Neurophysiologic Aspects | |
Normal Hippocampal and Temporal Anatomy | p. 93 |
Hippocampal Sclerosis: Pathology, Electrophysiology, and Mechanisms of Epileptogenesis | p. 105 |
Genetics and Epidemiology | |
Genetic Aspects of Epilepsy | p. 115 |
The Epidemiology of Epilepsy | p. 131 |
Remission, Intractability, Mortality, and Comorbidity of Seizures | p. 139 |
Basic Principles of Electroencephalography | |
Neurophysiologic Basis of the Electroencephalogram | p. 149 |
Polarity, Localization, and Field Determination in Electroencephalography | p. 165 |
Clinical Use of the Electroencephalogram in the Diagnosis of Epilepsy | p. 193 |
Computer-Assisted Data Collection and Analysis | p. 209 |
Electroencephalographic Atlas of Epileptiform Abnormalities | p. 225 |
Epileptic Seizures and Syndromes | |
Epileptic Seizures | |
Classification of Seizures | p. 287 |
Proposal for Revised Clinical and Electrographic Classification of Epileptic Seizures: Commission on Classification and Terminology of the International League Against Epilepsy | p. 291 |
Epileptic Auras | p. 299 |
Complex Partial Seizures | p. 309 |
Focal Motor Seizures and Epilepsia Partialis Continua | p. 329 |
Supplementary Sensorimotor Area Seizures | p. 345 |
Absence Seizures | p. 357 |
Generalized Tonic-Clonic Seizures | p. 369 |
Myoclonic Seizures | p. 395 |
Tonic and Atonic Seizures | p. 405 |
Infantile Spasms | p. 415 |
Epileptic Syndromes | |
Classification of the Epilepsies | p. 453 |
Proposal for Revised Classification of Epilepsies and Epileptic Syndromes: Commission on Classification and Terminology of the International League Against Epilepsy | p. 457 |
Symptomatic Focal Epilepsies | p. 467 |
Idiopathic and Benign Partial Epilepsies | p. 475 |
Childhood and Juvenile Absence Epilepsies | p. 485 |
Juvenile Myoclonic Epilepsy | p. 491 |
The Progressive Myoclonus Epilepsies | p. 509 |
Symptomatic Generalized Epilepsy and Lennox-Gastaut Syndrome | p. 525 |
Epilepsy with Reflex Seizures | p. 537 |
Less Common Epilepsy Syndromes | p. 551 |
Seizures in Special Clinical Settings | |
Neonatal Seizures | p. 577 |
Febrile Seizures | p. 601 |
Posttraumatic Epilepsy | p. 609 |
Brain Tumors and Epilepsy | p. 615 |
Epilepsy in the Setting of Neurocutaneous Syndromes | p. 627 |
Epilepsy in the Setting of Inherited Metabolic and Mitochondrial Disorders | p. 637 |
Seizures Associated with Nonneurologic Medical Conditions | p. 657 |
Catamenial Epilepsy and Issues of Fertility, Sexuality, and Reproduction | p. 671 |
Status Epilepticus | p. 681 |
Differential Diagnosis of Epilepsy | |
Psychogenic Seizures | p. 699 |
Other Nonepileptic Paroxysmal Disorders | p. 705 |
Antiepileptic Medications | |
General Principles of Antiepileptic Drug Therapy | |
Antiepileptic Drug Development | p. 719 |
Pharmacokinetics and Pharmacodynamics of Antiepileptic Drugs | p. 729 |
Pharmacokinetics in Infancy, Childhood, and Adolescence | p. 741 |
Initiating Drug Therapy | p. 759 |
Long-Term Therapy with Antiepileptic Drugs | p. 769 |
Treatment of Epilepsy During Pregnancy | p. 775 |
Treatment of Epilepsy in the Elderly | p. 787 |
Treatment of Epilepsy in the Setting of Renal and Liver Disease | p. 795 |
Discontinuting Antiepileptic Drug Therapy | p. 811 |
Specific Antiepileptic Medications and Other Therapies | |
Carbamazepine and Oxcarbazepine | p. 821 |
Valproate | p. 843 |
Phenytoin and Fosphenytoin | p. 853 |
Phenobarbital and Primidone | p. 869 |
Ethosuximide | p. 881 |
Benzodiazepines | p. 893 |
Gabapentin | p. 915 |
Lamotrigine | p. 933 |
Topiramate | p. 939 |
Tiagabine | p. 947 |
Felbamate | p. 953 |
Vigabatrin | p. 61 |
Adrenocorticotropin and Steroids | p. 969 |
Newer Antiepileptic Drugs | p. 977 |
Less Commonly Used Antiepileptic Drugs | p. 985 |
The Ketogenic Diet | p. 1001 |
Vagus Nerve Stimulation | p. 1007 |
Epilepsy Surgery | |
Identification of Candidates and Presurgical Evaluation | |
Recognition of Potential Surgical Candidates and Video Electroencephalography Evaluation | p. 1019 |
MRI Techniques in the Evaluation for Epilepsy Surgery | p. 1031 |
The Intracarotid Amobarbital Procedure | p. 1043 |
Metabolic and Functional Neuroimaging | p. 1053 |
Intracranial Electroencephalography and Localization Studies | p. 1067 |
Epilepsy Surgery in Specifics Settings | |
Selection of Candidates for Temporal Resection | p. 1077 |
Selection of Candidates for Extratemporal Resection | p. 1095 |
Resection for Epilepsy in the Setting of a Focal Lesion on MRI | p. 1115 |
Resection for Epilepsy in the Setting of a Nonlocalizing MRI | p. 1135 |
Hemispherectomy | p. 1147 |
Epilepsy Surgery in Infants and Children | p. 1161 |
Corpus Callosotomy and Multiple Subpial Transection | p. 1175 |
New Techniques: Gamma Knife | p. 1185 |
Deep Brain Stimulation for Epilepsy | p. 1193 |
Outcome and Complications of Epilepsy Surgery | p. 1197 |
Psychosocial Aspects of Epilepsy | |
Cognitive Effects of Epilepsy and Antiepileptic Medications | p. 1215 |
Psychiatric Aspects of Epilepsy | p. 1227 |
Quality of Life with Epilepsy | p. 1243 |
Legal Aspects of Epilepsy | p. 1251 |
Indications for Antiepileptic Drugs Sanctioned by the United States Food and Drug Administration | p. 1257 |
Subject Index | p. 1259 |
Table of Contents provided by Syndetics. All Rights Reserved. |